Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2005
06/16/2005US20050130983 2-{5-[4-(2-Acetoxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-5-ethyl-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one; inflammatory and cardiovascular diseases
06/16/2005US20050130980 Novel imidazopyrazines as cyclin dependent kinase inhibitors
06/16/2005US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130957 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them
06/16/2005US20050130955 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methyl cellulose solution at 37 degrees especially mixed with a polymer, such as methyl cellulose and/or hydroxypropylmethyl cellulose.
06/16/2005US20050130952 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005DE10354628A1 2-Ethyl-4,6-dimethyl-phenyl-substituierte Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547248A1 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
06/16/2005CA2539575A1 Method of removing transition metals, especially from metathesis reaction products
06/15/2005EP1541582A1 Process for producing indolopyrrolocarbazole derivative
06/15/2005EP1541575A1 Novel process for producing imidazo(1,2-b)pyridazine derivative
06/15/2005EP1541230A1 Molded catalyst for production of triethylenediamine, method for its production, and method for producing triethylenediamine
06/15/2005EP1540170A1 Roller tappet with cold advance
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539764A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539762A2 Bicyclic pyrimidinones as coagulation cascade inhibitors
06/15/2005EP1539761A1 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539743A1 Pyrazole derivatives as gnrh inhibitors
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539714A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/15/2005EP1539219A2 Affinity small molecules for the epo receptor
06/15/2005EP1539188A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539178A2 Protease inhibitors
06/15/2005EP1539168A2 Treatment of neuropathic pain with 6h-pyrrolo(3,4-d)pyridazine compounds
06/15/2005EP1539154A2 Methods for regulating transcription by targeting quadruplex dna
06/15/2005EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP0971927B1 Improved methods of making cross-bridged macropolycycles
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628115A 哌啶衍生物 Piperidine derivatives
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1206535C Modulating multiple lineage kinase proteins
06/15/2005CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
06/14/2005US6906189 Catalysts and methods for catalytic oxidation
06/14/2005US6906096 Drug libraries
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6906060 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6906050 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis
06/14/2005US6905749 data can be recorded using a bluish-violet laser beam having wavelength of 390 to 420 nm and from which data can be reproduced using a bluish-violet laser beam wavelength of 390 to 420 nm, porphyrin dye coating system
06/14/2005CA2333703C Isothiazole derivatives useful as anticancer agents
06/14/2005CA2101178C New polycyclic polyamides as precursors for energetic polycyclic polynitramine oxidizers
06/09/2005WO2005052023A1 Hyperbranched polymers
06/09/2005WO2005051954A2 PROCESSES FOR THE PREPARATION OF PYRAZOLO[1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
06/09/2005WO2005051953A2 Pyrrolo-pyrazine derivatives useful as cb1-modulators
06/09/2005WO2005051917A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051394A1 Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005037836A3 Imidazo ‘1, 5 - a ! pyrazine tyrosine kinase inhibitors
06/09/2005WO2005028475A3 Compositions useful as inhibitors of protein kinases
06/09/2005WO2005011609A3 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124806 Process for preparation of substituted amino alcohols
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124638 Benzimidazoles and analogs thereof as antivirals
06/09/2005US20050124635 Process for the preparation of tubulin inhibitors
06/09/2005US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
06/09/2005US20050124623 For example, 2-(4-Benzoyl-piperazin-1-yl)-3-(4-chloro-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-oxo-propionitrile; useful for the treatment of HIV and AIDS
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124619 Medical devices employing triazine compounds and compositions thereof
06/09/2005US20050124616 prophylaxis and treatment of herpes viral infections; e.g. N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-c]pyrimidin-7-amine
06/09/2005US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
06/09/2005US20050124596 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123800 Organic compound and organic light emitting device using the same
06/09/2005US20050123597 Releasable linkage and compositions containing same
06/09/2005DE10351647A1 2-Halogen-6-alkyl-phenyl substituierte Tetramsäure-Derivate 2-halo-6-alkyl-phenyl substituted tetramic acid derivatives
06/09/2005DE10349671A1 New pyrazinopyrimidine or pyrazinoimidazole derivatives useful for weight reduction in mammals, for preventing or treating obesity, type II diabetes or metabolic syndrome and for treating sexual disorders
06/09/2005DE10260618B4 Tumorhemmende annellierte Azepinonderivate Tumor-inhibiting fused Azepinonderivate
06/09/2005CA2546740A1 Hyperbranched polymers
06/09/2005CA2546652A1 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546318A1 Pyrrolo-pyrazine derivatives useful as cb1-modulators
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/08/2005EP1538185A1 Colored curable composition, color filter and manufacturing method thereof
06/08/2005EP1538151A1 Artificial oxygen carrier and production method thereof
06/08/2005EP1537867A1 Method of photodynamic diagnosis for vascular diseases
06/08/2005EP1537181A1 Metaloxyphthalocyanine compounds
06/08/2005EP1537117A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 573